241 results on '"Piotrowski, Wojciech J."'
Search Results
2. Interleukin 16 and 25 (IL-17E) and Clinical Outcomes in Exacerbation of COPD—A Pilot Study.
3. The Short-Term Efficacy of a Three-Week Pulmonary Rehabilitation Program among Patients with Obstructive Lung Diseases
4. More than a Genetic Code: Epigenetics of Lung Fibrosis
5. Gender differences in health-related quality of life measured by the Sarcoidosis Health Questionnaire
6. Eosinopenia and neutrophil-to-lymphocyte count ratio as prognostic factors in exacerbation of COPD
7. Characteristics of Interstitial Pneumonia With Autoimmune Features (IPAF): Protocol for a Multicenter Prospective Study
8. Is Pulmonary Involvement a Distinct Phenotype of Post-COVID-19?
9. A pilot study of daily telemonitoring to predict acute exacerbation in chronic obstructive pulmonary disease
10. Untypical Manifestations of Granulomatosis with Polyangiitis—A Review of the Literature
11. Expectations, symptoms, and quality of life before and after 1 year of Pirfenidone treatment in patients with idiopathic pulmonary fibrosis: A single‐arm, open‐label nonrandomized study
12. Calcium, Phosphate, and Vitamin D Status in Patients with Sarcoidosis—Associations with Disease Activity and Symptoms
13. Oxidative Biomarkers Associated with the Pulmonary Manifestation of Post-COVID-19 Complications
14. A multicentre retrospective observational study on Polish experience of pirfenidone therapy in patients with idiopathic pulmonary fibrosis: the PolExPIR study
15. Concise, Practical Review on Transthoracic Lung Ultrasound in Prehospital Diagnosis of Dyspnea in Adults
16. The use of simple pulmonary function tests in the post-COVID-19 pulmonary improvement prediction: lessons from a single-center study
17. Fizjoterapia w wybranych specjalizacjach medycznych
18. Soluble ITGaM and ITGb2 Integrin Subunits Are Involved in Long-Term Pulmonary Complications after COVID-19 Infection
19. Characteristics of Interstitial Pneumonia With Autoimmune Features (IPAF): Protocol for a Multicenter Prospective Study (Preprint)
20. Altered Cyclooxygenase-2 Expression in Pulmonary Sarcoidosis is not Related to Clinical Classifications
21. Double Lung Transplantation for Idiopathic Pulmonary Fibrosis in a Patient with a History of Liver Transplantation and Prolonged Journey for Disease-Specific Antifibrotic Therapy
22. COVID-19 in patients with pulmonary alveolar proteinosis: a European multicentre study
23. sj-docx-1-taj-10.1177_20406223221117982 – Supplemental material for Therapeutic decisions in a cohort of patients with idiopathic pulmonary fibrosis: a multicenter, prospective survey from Poland
24. Longitudinal and Comparative Measures of Serum Chitotriosidase and YKL-40 in Patients With Idiopathic Pulmonary Fibrosis
25. The Utility of Telemedicine In Managing Patients After COVID 19
26. Therapeutic decisions in a cohort of patients with idiopathic pulmonary fibrosis: a multicenter, prospective survey from Poland
27. The Role of Interaction between Mitochondria and the Extracellular Matrix in the Development of Idiopathic Pulmonary Fibrosis
28. Serial Measurements of Circulating KL-6, SP-D, MMP-7, CA19-9, CA-125, CCL18, and Periostin in Patients with Idiopathic Pulmonary Fibrosis Receiving Antifibrotic Therapy: An Exploratory Study
29. Proteomic profiling of peripheral blood and bronchoalveolar lavage fluid in interstitial lung diseases : an explorative study
30. Exhaled 8-isoprostane in sarcoidosis: relation to superoxide anion production by bronchoalveolar lavage cells
31. Evaluation of Selected IL6/STAT3 Pathway Molecules and miRNA Expression in Chronic Obstructive Pulmonary Disease - the Search for New Diagnostic Markers
32. Proteomic profiling of peripheral blood and bronchoalveolar lavage fluid in interstitial lung diseases: an explorative study
33. Air Pollution—An Overlooked Risk Factor for Idiopathic Pulmonary Fibrosis
34. The role of bronchoscopy in diagnosis of chronic cough in adults: a retrospective single-center study
35. Telemetric observation of the course and treatment effects of selected interstitial lung diseases associated with connective tissue diseases (CTD-ILD) – protocol presentation
36. Low level of serum free triiodothyronine can be a predictor of long-term mortality after COPD exacerbations
37. The Prognostic Value of Fixed Time and Self-Paced Walking Tests in Patients Diagnosed with Idiopathic Pulmonary Fibrosis
38. Unusually high plasma values of many tumour markers in a patient with idiopathic pulmonary fibrosis
39. Eicosanoids in Exhaled Breath Condensate and BAL Fluid of Patients With Sarcoidosis*
40. Atypical Lung Changes in a 19-Year-Old Woman with Crohnʼs Disease
41. Stanowisko Polskiego Towarzystwa Chorób Płuc i Polskiego Towarzystwa Alergologicznego dotyczące leczenia powikłań płucnych u chorych po przebytym zakażeniu SARS-CoV-2.
42. Telomere Abnormalities in the Pathobiology of Idiopathic Pulmonary Fibrosis
43. Test QuantiFERON-TB-GOLD In-Tube u chorych na sarkoidozę
44. Exhaled 8-isoprostane as a prognostic marker in sarcoidosis. A short term follow-up
45. Mitochondrial functioning abnormalities observed in blood platelets of chronic smoke-exposed guinea pigs – a pilot study
46. The prognostic value of fixed time and self-paced walking tests in patients diagnosed with idiopathic pulmonary fibrosis.
47. Diagnosis of sarcoidosis -- the updated ATS 2020 recommendations through the prism of everyday clinical practice.
48. Guidelines of the Polish Respiratory Society for diagnosis and treatment of idiopathic pulmonary fibrosis.
49. Mitochondrial functioning abnormalities observed in blood platelets of chronic smoke-exposed guinea pigs – a pilot study
50. Czy bronchoskopia jest zawsze niezbędna w diagnostyce krwioplucia?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.